SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-017658
Filing Date
2024-06-20
Accepted
2024-06-20 16:35:17
Documents
1
Period of Report
2024-06-17

Document Format Files

Seq Description Document Type Size
1 form4-06202024_040613.html 4  
1 form4-06202024_040613.xml 4 3994
  Complete submission text file 0001415889-24-017658.txt   5513
Mailing Address C/O SYNDAX PHARMACEUTICALS, INC. 400 TOTTEN POND ROAD, SUITE 110 WALTHAM MA 02451
Business Address
Morrison Briggs (Reporting) CIK: 0001654430 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39335 | Film No.: 241056833

Mailing Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9
Business Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9 (857) 412-7018
Repare Therapeutics Inc. (Issuer) CIK: 0001808158 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)